Hikma Pharmaceuticals plc. financial statements, including revenue, expenses, profit, and loss
The total revenue of HKMPY for the last semiannual is 1.44 B USD, and it's 0.67% higher compared to the previous semiannual. The net income of H2 23 is 58.53 M USD.